Roche and reMYND Enter Agreement to Develop First-in-Class Disease-Modifying Treatments for Parkinson’s and Alzheimer’s Disease 07 September 2010 Novel therapies to target unmet needs in neurodegenerative disorders.
Novozymes Announces Master File for Recombinant Albumin 03 September 2010 The dossier, containing information on the manufacture and safety of albucult, can help support the medical devices and drug formulation applications.
Key Bio Nano Consulting Partner Develops Nanolitre Scale Technique for Determining Protein Stability and Ligand-Binding Affinity 26 August 2010 BNC to provide commercial access to new technique enabling evaluation of low expressing proteins without the need for fluorescent tags.
Nature Medicine Publishes AVI BioPharma Preclinical Studies 25 August 2010 Study demonstrates post-exposure efficacy of PMOplus™ Oligomers against Ebola and Marburg Viruses.
Agilent and Johns Hopkins to Research Toxicity Pathways for Embryonic Brain Development Using Metabolomics 20 August 2010 The work could help identify possible contributions of chemicals to disorders such as autism and attention hyperactivity disorders.
Clavis Recruits First Patient in Pivotal Phase III Study of Elacytarabine in Late-Stage Acute Myeloid Leukaemia 19 August 2010 Clinical trial aims to confirm significant survival benefit seen in Phase II.
Midatech and Monosol Rx Announce Filing of Joint Patent Application for Nanoparticle Film Delivery Systems 19 August 2010 The applications submitted to USPTO relate to therapeutic uses of nanoparticle-based proteins and peptides delivered in pharmaceutical films.
NoAb BioDiscoveries and VigiCell Enter into a Collaboration and Co-Distribution Agreement 19 August 2010 The companies have signed an agreement in principle to collaborate and co-distribute each other’s complementary drug discovery services.